Divi's Laboratories (NSE:DIVISLAB) FCF Margin % : 0.00% (As of Mar. 2025)

View and export this data going back to 2003. Start your Free Trial

What is Divi's Laboratories FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Divi's Laboratories's Free Cash Flow for the three months ended in Mar. 2025 was ₹0 Mil. Divi's Laboratories's Revenue for the three months ended in Mar. 2025 was ₹25,850 Mil. Therefore, Divi's Laboratories's FCF Margin % for the quarter that ended in Mar. 2025 was 0.00%.

As of today, Divi's Laboratories's current FCF Yield % is 0.12%.

The historical rank and industry rank for Divi's Laboratories's FCF Margin % or its related term are showing as below:

NSE:DIVISLAB' s FCF Margin % Range Over the Past 10 Years
Min: 0.62 Med: 13.4 Max: 25.91
Current: 2.3

During the past 13 years, the highest FCF Margin % of Divi's Laboratories was 25.91%. The lowest was 0.62%. And the median was 13.40%.

NSE:DIVISLAB's FCF Margin % is ranked better than
53.81% of 972 companies
in the Drug Manufacturers industry
Industry Median: 0.89 vs NSE:DIVISLAB: 2.30

Divi's Laboratories FCF Margin % Historical Data

The historical data trend for Divi's Laboratories's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Divi's Laboratories FCF Margin % Chart

Divi's Laboratories Annual Data

Trend

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Mar25

FCF Margin %

Get a 7-Day Free Trial

15.12

13.62

25.91

3.29

2.30

Divi's Laboratories Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
FCF Margin %	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of Divi's Laboratories's FCF Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Divi's Laboratories's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Divi's Laboratories's FCF Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Divi's Laboratories's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Divi's Laboratories's FCF Margin % falls into.

Save Embed

;

Save Embed

;

Divi's Laboratories FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Divi's Laboratories's FCF Margin for the fiscal year that ended in Mar. 2025 is calculated as

FCF Margin	=	Free Cash Flow (A: Mar. 2025 )	/	Revenue (A: Mar. 2025 )
	=	2150	/	93600
	=	2.30 %

Divi's Laboratories's FCF Margin for the quarter that ended in Mar. 2025 is calculated as

FCF Margin	=	Free Cash Flow (Q: Mar. 2025 )	/	Revenue (Q: Mar. 2025 )
	=	0	/	25850
	=	0.00 %

Divi's Laboratories FCF Margin % Related Terms

Thank you for viewing the detailed overview of Divi's Laboratories's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Divi's Laboratories Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Divi's Laboratories Ltd (NSE:DIVISLAB) » Definitions » FCF Margin %

Traded in Other Exchanges

532488:India

Address

Cyber Hills, Divi Towers, 1-72/23(P)/DIVIS/303, Gachibowli, Hyderabad, TG, IND, 500032

Website

https://www.divislabs.com

Divi's Laboratories Ltd is a specialty and generic drug manufacturing company. It is engaged in the manufacture of Active Pharmaceutical ingredients (API), Intermediates, and Nutraceutical ingredients with a predominance in exports. It also through its custom synthesis, supports pharma companies for their patented products business from gram scale requirements for clinical trials to launch as well as late life cycle management. Geographically, the company derives a majority of its revenue through exports to countries like the United States of America, Switzerland, and other countries.

Divi's Laboratories Headlines

No Headlines